Home » Topics » Conferences

Conferences
RSS

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

Potent new antimalarial trioxanes developed at Johns Hopkins

Sep. 2, 1998

SNAP-8719: a valuable tool for studying alpha1D-adrenoceptor function

Sep. 2, 1998

PEG-hirudin more effective than heparin in patients with acute coronary syndromes

Sep. 2, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Novartis continues to study DPP IV inhibitors; new lead reported at ACS meeting

Sep. 1, 1998

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Sep. 1, 1998

Novo Nordisk describes the first nonpeptide competitive glucagon antagonist

Sep. 1, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...